HPV-16/18 vaccine

PreclinicalVaccine

SShanghai Zerun Biotechnology Co.,Ltd

HPV-16/18 vaccine is one of 36 biologic programs targeting Papilloma. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

PapillomaActive, not recruiting

PapillomaPreclinical

Active, not recruiting

Competition

Competitive Landscape

150 competitors in Papilloma

#DrugCompanyPhaseTrials

Cervarix

GSK

Phase 3

9 2

GSK 257049

GSK

Phase 3

6 3

Comparator: Pbo

Merck & Co.

Phase 3

3 4

Gardasil

Merck & Co.

Phase 3

11 5

Engerix-B

GSK

Phase 3

1 6

Havrix

GSK

Phase 3

1 7

Fludara

Sanofi

Phase 2

2 8

Opdivo

Bristol-Myers Squibb

Phase 2

1 9

Libtayo

Regeneron

Phase 2

1 10

Boostrix

GSK

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Papilloma4 trials

Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women

Active, not recruiting·SShanghai Zerun Biotechnology Co.,Ltd··NCT06776055·5,372 enrolled

Human Papillomavirus (HPV) Vaccine (Cervarix TM) Efficacy, Immunogenicity & Safety Trial in Adult Japanese Women With GSK Biologicals HPV-16/18 Vaccine

Completed· GSK logo

GSK·Phase 2·NCT00316693·1,046 enrolled

Evaluating the 2-dose Immunization Schedule of Human Papillomavirus (HPV)-16/18 in Adolescent Females

Completed·SShanghai Zerun Biotechnology Co.,Ltd·Phase 2·NCT02740777·900 enrolled

Show 1 more trial

A Phase III Study of Human Papillomavirus (HPV)-16/18 Vaccine.

Completed·SShanghai Zerun Biotechnology Co.,Ltd·Phase 3·NCT02733068·12,000 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for HPV-16/18 vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — HPV-16/18 vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for HPV-16/18 vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Shanghai Zerun Biotechnology Co.,Ltd company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: SShanghai Zerun Biotechnology Co.,Ltd

HPV-16/18 vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Papilloma4 trials

References

Drug Info

Quick Facts

Related News